These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16166787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
    Gu B, Gates AT, Isken O, Behrens SE, Sarisky RT.
    J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.
    Date T, Kato T, Kato J, Takahashi H, Morikawa K, Akazawa D, Murayama A, Tanaka-Kaneko K, Sata T, Tanaka Y, Mizokami M, Wakita T.
    J Virol; 2012 Oct; 86(19):10805-20. PubMed ID: 22787209
    [Abstract] [Full Text] [Related]

  • 6. Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells.
    Date T, Kato T, Miyamoto M, Zhao Z, Yasui K, Mizokami M, Wakita T.
    J Biol Chem; 2004 May 21; 279(21):22371-6. PubMed ID: 14990575
    [Abstract] [Full Text] [Related]

  • 7. An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain.
    Date T, Miyamoto M, Kato T, Morikawa K, Murayama A, Akazawa D, Tanabe J, Sone S, Mizokami M, Wakita T.
    Hepatol Res; 2007 Jun 21; 37(6):433-43. PubMed ID: 17437527
    [Abstract] [Full Text] [Related]

  • 8. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
    Elshaffei IM, Gupta N, Wu CH, Wu DC, Hammad LN, Abo-Elmatty DM, Mesbah NM, Wu GY.
    J Dig Dis; 2015 Aug 21; 16(8):449-55. PubMed ID: 25873200
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
    Wose Kinge CN, Espiritu C, Prabdial-Sing N, Sithebe NP, Saeed M, Rice CM.
    Antimicrob Agents Chemother; 2014 Sep 21; 58(9):5386-94. PubMed ID: 24982066
    [Abstract] [Full Text] [Related]

  • 10. Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon.
    Targett-Adams P, McLauchlan J.
    J Gen Virol; 2005 Nov 21; 86(Pt 11):3075-3080. PubMed ID: 16227230
    [Abstract] [Full Text] [Related]

  • 11. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
    Kato T, Date T, Miyamoto M, Sugiyama M, Tanaka Y, Orito E, Ohno T, Sugihara K, Hasegawa I, Fujiwara K, Ito K, Ozasa A, Mizokami M, Wakita T.
    J Clin Microbiol; 2005 Nov 21; 43(11):5679-84. PubMed ID: 16272504
    [Abstract] [Full Text] [Related]

  • 12. SEC14L2 enables pan-genotype HCV replication in cell culture.
    Saeed M, Andreo U, Chung HY, Espiritu C, Branch AD, Silva JM, Rice CM.
    Nature; 2015 Aug 27; 524(7566):471-5. PubMed ID: 26266980
    [Abstract] [Full Text] [Related]

  • 13. Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro.
    Kato N, Sugiyama K, Namba K, Dansako H, Nakamura T, Takami M, Naka K, Nozaki A, Shimotohno K.
    Biochem Biophys Res Commun; 2003 Jul 04; 306(3):756-66. PubMed ID: 12810084
    [Abstract] [Full Text] [Related]

  • 14. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M, Corsa AC, Xu S, Peng B, Gong R, Lee YJ, Chan K, Mo H, Delaney W, Cheng G.
    Antiviral Res; 2013 Nov 04; 100(2):439-45. PubMed ID: 24013001
    [Abstract] [Full Text] [Related]

  • 15. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
    Date T, Morikawa K, Tanaka Y, Tanaka-Kaneko K, Sata T, Mizokami M, Wakita T.
    Microbiol Immunol; 2012 May 04; 56(5):308-17. PubMed ID: 22320232
    [Abstract] [Full Text] [Related]

  • 16. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
    Graziani R, Paonessa G.
    J Gen Virol; 2004 Jul 04; 85(Pt 7):1867-1875. PubMed ID: 15218171
    [Abstract] [Full Text] [Related]

  • 17. Subgenomic replicon derived from a cell line infected with the hepatitis C virus.
    Kishine H, Sugiyama K, Hijikata M, Kato N, Takahashi H, Noshi T, Nio Y, Hosaka M, Miyanari Y, Shimotohno K.
    Biochem Biophys Res Commun; 2002 May 10; 293(3):993-9. PubMed ID: 12051758
    [Abstract] [Full Text] [Related]

  • 18. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.
    Abe K, Ikeda M, Dansako H, Naka K, Shimotohno K, Kato N.
    Virus Res; 2005 Jan 10; 107(1):73-81. PubMed ID: 15567036
    [Abstract] [Full Text] [Related]

  • 19. Subgenomic hepatitis C virus replicons inducing expression of a secreted enzymatic reporter protein.
    Yi M, Bodola F, Lemon SM.
    Virology; 2002 Dec 20; 304(2):197-210. PubMed ID: 12504562
    [Abstract] [Full Text] [Related]

  • 20. HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A.
    Abe K, Ikeda M, Ariumi Y, Dansako H, Wakita T, Kato N.
    Arch Virol; 2009 Dec 20; 154(10):1671-7. PubMed ID: 19779801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.